{"created":"2023-05-15T14:46:21.919505+00:00","id":63635,"links":{},"metadata":{"_buckets":{"deposit":"1f1b545f-ccb6-4da4-8029-7fa1151b3d32"},"_deposit":{"created_by":1,"id":"63635","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"63635"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00063635","sets":["10:29"]},"author_link":["628093","628091","628092"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2009-10-03","subitem_date_issued_type":"Issued"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"第49回日本核医学会学術総会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"関根, 瑞保"}],"nameIdentifiers":[{"nameIdentifier":"628091","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"その他"}],"nameIdentifiers":[{"nameIdentifier":"628092","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"関根 瑞保","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"628093","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"(S,S)-[18F]FMeNER-D2を用いた抗うつ薬のノルエピネフリントランスポーター占有率測定","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"(S,S)-[18F]FMeNER-D2を用いた抗うつ薬のノルエピネフリントランスポーター占有率測定"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2009-10-08"},"publish_date":"2009-10-08","publish_status":"0","recid":"63635","relation_version_is_last":true,"title":["(S,S)-[18F]FMeNER-D2を用いた抗うつ薬のノルエピネフリントランスポーター占有率測定"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:20:44.264382+00:00"}